Abstract |
We discovered a congenital heterozygous dysfibrinogen in a patient and reported this case in relation to surgery some time ago (Jpn J Surg (1988) 18:43-46). Further studies on the isolated abnormal population of fibrinogen derived from this patient have revealed that fibrinopeptide A was not cleaved by ancrod, a snake venom-derived thrombin-like enzyme, but by thrombin, slowly but completely. The released fibrinopeptide A components, being the A, AY, and AP peptides, were all found to be abnormal, as evidenced by slightly earlier elution positions on high-performance liquid chromatography, compared with the normal counterparts. By analyzing their amino acid sequence, we have identified an arginine to histidine substitution at position 16 of the A alpha chain, the thrombin cleavage site. Utilizing insolubilized abnormal fibrinogen, we confirmed that the polymerization site assigned to the central E domain, the "A" site, was exposed by thrombin, but not by ancrod. This dysfibrinogen, designated as fibrinogen Osaka IV, is the second abnormal molecule with an A alpha arginine-16 to histidine substitution identified among Japanese families.
|
Authors | K Yamazumi, S Terukina, M Matsuda, J Kanbayashi, M Sakon, T Tsujinaka |
Journal | Surgery today
(Surg Today)
Vol. 23
Issue 1
Pg. 45-50
( 1993)
ISSN: 0941-1291 [Print] Japan |
PMID | 8461606
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fibrinogens, Abnormal
- fibrinogen Osaka IV
- Fibrinopeptide A
- Histidine
- Arginine
- Ancrod
|
Topics |
- Afibrinogenemia
(congenital, genetics)
- Amino Acid Sequence
- Ancrod
- Arginine
(chemistry)
- Chromatography, High Pressure Liquid
- Fibrinogens, Abnormal
(chemistry)
- Fibrinopeptide A
(chemistry)
- Histidine
(chemistry)
- Humans
- Male
- Middle Aged
- Molecular Sequence Data
|